Amanote Research

Amanote Research

    RegisterSign In

Selective Inhibitors for JNK Signalling: A Potential Targeted Therapy in Cancer

Journal of Enzyme Inhibition and Medicinal Chemistry - United Kingdom
doi 10.1080/14756366.2020.1720013
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineDrug DiscoveryPharmacology
Date

January 1, 2020

Authors
Qinghua WuWenda WuVesna JacevicTanos C. C. FrancaXu WangKamil Kuca
Publisher

Informa UK Limited


Related search

Targeted Cancer Therapy With Ribosome Biogenesis Inhibitors: A Real Possibility?

Oncotarget
Oncology
2015English

Identification of Selective Inhibitors of Helicobacter Pylori IMPDH as a Targeted Therapy for the Infection

Scientific Reports
Multidisciplinary
2019English

EGFR-targeted Cancer Therapy: Promise, Problems and Potential Solutions

Translational Medicine
2011English

Angiogenesis Inhibitors for Cancer Therapy

Biomedical Journal of Scientific & Technical Research
2018English

Targeted Therapy for Breast Cancer Prevention

Frontiers in Oncology
Cancer ResearchOncology
2013English

Arginine Deprivation as a Targeted Therapy for Cancer

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2008English

Targeted Therapy in Gastric Cancer

European Surgery - Acta Chirurgica Austriaca
Surgery
2016English

Covalent JNK Inhibitors?

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Recent Advances in CDK Inhibitors for Cancer Therapy

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy